Cutaneous larva migrans: The creeping eruption

Cutis

Volumn 72, Issue 2, 2003, Pages 111-115

  Brenner, Marc A ^a   Patel, Mital B ^b,c  

^a Institute for Medical Research   (United States)

^b Passaic Beth Israel Hospital   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIINFECTIVE AGENT; ANTIMONY; CARBON DIOXIDE; CHLOROETHANE; CHLOROQUINE; CITRIC ACID; DIETHYLCARBAMAZINE; IVERMECTIN; LIQUID NITROGEN; MEBENDAZOLE; PHENOL; TIABENDAZOLE;

ANCYLOSTOMA CANINUM; ARM; ARTICLE; BACTERIAL INFECTION; BREAST; BUTTOCK; CARIBBEAN ISLANDS; CAT; CAUTERIZATION; CELLULITIS; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DOG; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; ENTEROCOLITIS; EPIDERMOLYSIS; ERYTHEMA; ERYTHEMA MULTIFORME; FECES; FOOT; GASTROINTESTINAL TRACT; HOOKWORM; HOST; HUMAN; LARVA; LARVA MIGRANS; LOEFFLER PNEUMONIA; NAUSEA; NONHUMAN; PARASITE; PARASITE MIGRATION; PROGNOSIS; PRURITUS; RISK FACTOR; SEASHORE; SEIZURE; SITTING; SKIN DISEASE; SKIN MANIFESTATION; SUPERINFECTION; VOMITING; WALKING;

ANIMALS; CATS; DOGS; HUMANS; LARVA MIGRANS; TRAVEL;

EID: 0141889954     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Douglass MC, Juzych LA. Cutaneous larva migrans. Emedicine [serial online]. 2001;2(11):1-9. Available at: http://www.emedicine.com. Accessed July 5, 2002.
2. Davies HD, Sakuls P, Keystone JS. Creeping eruption: a review of clinical presentation and management of 60 cases presenting to a tropical disease unit. Arch Dermatol. 1993;129:588-591.
3. Henry JB. Clinical Diagnosis and Management by Laboratory Methods. 20th ed. Philadelphia, Pa: WB Saunders, 2001.
4. Blackwell V, Vega-Lopez F. Cutaneous larva migrans: clinical features and management of 44 cases presenting in the returning traveler. Br J Dermatol. 2001;145:434-437.
5. Le EH, Hsu S. Photo quiz: a serpiginous eruption on the buttocks. Am Fam Physician. 2000;62:2493-2494.
6. Jelinek T, Maiwald H, Nothdurft HD, et al. Cutaneous larva migrans in travelers: synopsis of histories, symptoms, and treatment of 98 patients. Clin Infect Dis. 1994;19:1062-1066.
7. Mattone-Volpe F. Cutaneous larva migrans infection in the pediatric foot: a review and two case reports. J Am Podiatr Med Assoc. 1998;88:228-231.
8. Hotez PJ, Narasimhan S, Haggerty J, et al. Hyaluronidase from infective Ancylostoma hookworm larvae and its possible function as a virulence factor in tissue invasion and in cutaneous larva migrans. Infect Immun. 1992;60:1018-1023.
9. Jones WB 2nd. Cutaneous larva migrans. South Med J. 1993;86:1311-1313.
10. Elgart ML. Creeping eruption. Arch Dermatol. 1998;134:619-620.
11. Bouchaud O, Houze S, Schiemann R, et al. Cutaneous larva migrans in travelers: a prospective study, with assessment of therapy with ivermectin. Clin Infect Dis. 2000;31:493-498.
12. Mackey SL, Wagner KF. Dermatologic manifestations of parasitic disease. Infect Dis Clin North Am. 1994;8:713-743.
13. Miller AC, Walker J, Jaworski R, et al. Hookworm folliculitis. Arch Dermatol. 1991;127:547-549.
14. Martinez Fernandez R, Alvarez J, Cabo F, et al. Cutaneous lesions and lung infiltrates after trip to Thailand. Rev Clin Esp. 1995;195:721-722.
15. Rothe M, Kerdel FA, Farah FS. Cutaneous larva migrans. In: Demis DJ, ed. Clinical Dermatology. 22nd rev. Philadelphia, Pa: Lippincott Raven; 1995;sect 18-16:1-8.
16. Kahn G, Johnson JA. Serum IgE levels in cutaneous larva migrans. J Dermatol. 1971;10:201-203.
17. Stone OJ, Mullins JF. First use of thiabendazole in creeping eruption. Texas Rep Biol Med. 1963;21:422-424.
18. Katz R, Ziegler J, Blank H. The natural course of creeping eruption and treatment with thiabendazole. Arch Dermatol. 1965;91:420-424.
19. Jones SK. Cutaneous larva migrans - 'recurrens' [letter]. Br J Dermatol. 1994;130:546.
20. Rodilla F, Colomina J, Magraner J. Current treatment recommendations for cutaneous larva migrans [letter]. Ann Pharmacother. 1994;28:672-673.
21. Jones S, Reynolds N, Oliwiecki S, et al. Oral albendazole for the treatment of cutaneous larva migrans. Br J Dermatol. 1990;122:99-101.
22. Orihuela AR, Torres JR. Single dose of albendazole in the treatment of cutaneous larva migrans. Arch Dermatol. 1990;126:398-399.
23. Caumes E, Datry A, Paris L, et al. Efficacy of ivermectin in the therapy of cutaneous larva migrans. Arch Dermatol. 1992;128:994-995.
24. Caumes E, Carriere J, Guermonprez G, et al. Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit. Clin Infect Dis. 1995;20:542-548.
25. Richey TK, Gentry RH, Fitzpatrick JE, et al. Persistent cutaneous larva migrans due to Ancylostoma species. South Med J. 1996;89:609-611.